Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CUREVAC N.V.

(CVAC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Biotechnology & Medical Research
01/28SVB Leerink Adjusts Moderna's Price Target to $85 From $86, Maintains Underperform Rati..
MT
01/28AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Add Recommendatio..
MT
01/28Moderna, Pfizer Boosters Provide High Level of Protection Against Omicron, UK Health Se..
MT
01/27Lonza to Manufacture HaemaLogiX's Myeloma Drug Candidate KappaMab
MT
01/27Pfizer/BioNTech, Moderna COVID-19 Booster Shots Provide Protection Against Death from O..
MT
01/27HaemaLogiX Pty. Ltd. and Lonza Collaborates to Manufacture Kappamab, A Multiple Myeloma..
CI
01/27Moderna, IAVI Say Clinical Trial of Experimental HIV Vaccine Antigens is Underway
MT
01/26Pfizer-BioNTech, Moderna COVID-19 Jabs Shown Safe For Women Undergoing IVF in Study
MT
01/26Moderna Launches Mid-Stage Study of Omicron-Specific Booster Jab
MT
01/26Moderna starts trial for Omicron-specific booster shot
RE
01/26Moderna starts trial testing Omicron-specific booster shot
RE
01/26Moderna Starts Clinical Trial Of Booster Shot Targeting Omicron Covid Variant - CNBC
RE
01/26IQVIA Holdings Inc. Appoints Sheila A. Stamps to Board of Directors
CI
01/26Moderna's Shares Rise After Deutsche Bank Upgrade
MT
01/26Lonza Group Ltd. Appoints Marion Helmes as Independent Member of the Board of Directors..
CI
01/26Deutsche Bank Upgrades Moderna to Hold From Sell, Adjusts Price Target to $175 From $20..
MT
01/26Lonza Group to Seek Acquisitions
CI
01/26INSIDER SELL : Moderna
MT
01/26ANALYST RECOMMENDATIONS : Alphabet, IBM, Meta, Moderna, Netflix...
01/26COVID-19 Severity Appears Lower With Omicron, But High Hospitalization Volume Could Str..
MT
01/26Lonza Offers Rosy Outlook After Divisional Growth Leads 2021 Sales To Beat Market Expec..
MT
01/26Lonza Posts Higher 2021 Sales; Confirms Mid-Term Targets
DJ
01/26Lonza's full-year core EBITDA up 20.7% on vaccine demand
RE
01/26Lonza's FY21 Profit Triples After Strong Sales Growth in All Divisions
MT
01/26Lonza Group Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
01/26Lonza Group Ltd. Announces Sales Guidance for the Full-Year 2022
CI
01/26Lonza Group Ltd. Announces Board Changes
CI
01/26Lonza Group Ltd. Proposes Dividend for 2021
CI
01/25Lonza Gets US Injunction in Patent Infringement Case Against Adva Biotechnology
MT
01/25US Labor Department's OSHA Revokes COVID-19 Vaccination Order for Large Employers
MT
01/25EMA Says Clinical Data Published Supporting Extension Of Indication For Spikevax To Inc..
RE
01/25AlphaValue/Baader Europe Lowers Price Target on Lonza Group, Upgrades Recommendation to..
MT
01/25Seagen Canada Announces Availability of PADCEV« to Treat Advanced Bladder Cancer
CI
01/25J&J expects jump in COVID vaccine sales in 2022, eyes device deals
RE
01/25Germany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1
RE
01/24Leslie Wims Morris Joins IQVIA Board of Directors
CI
01/24Chile to purchase 2 million Moderna COVID-19 vaccine doses
RE
01/24INSIDER SELL : Moderna
MT
01/21Moderna's Valuation Has Come 'Back to Earth,' Become More Reasonable, BofA Securities S..
MT
01/21UBS Initiates Coverage on Moderna With Neutral Rating, $221 Price Target
MT
01/21BofA Securities Upgrades Moderna to Neutral From Underperform, Adjusts Price Target to ..
MT
01/20Moderna says aims to name 'country of choice' for COVID vaccine production in Africa so..
RE
01/20EMA Says Spikevax Product Information To Be Updated To Include Paraesthesia As Rare Sid..
RE
01/19Prior COVID infection more protective than vaccination during Delta surge, U.S. study f..
RE
01/19Valneva Shares Suffer as Coronavirus Vaccine Seen Arriving Too Late
DJ
01/18Lonza Signs Biologics Development Deal With Forbion, BioGeneration Ventures
MT
01/18US Stocks Slump as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on Financials
MT
01/18Seagen Inc. Announces Data from Phase I Clinical Trial Combining SEA-CD40
CI
01/18US Stocks Start Week Lower as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on ..
MT
01/18Morgan Stanley Adjusts Seagen Price Target to $178 From $181, Maintains Equalweight Rat..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on CUREVAC N.V.